Cytek Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

15 October 2025 -- California, US -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader Cytek Biosciences, Inc today announced the relocation of its European headquarters to a new facility in Amsterdam’s Life Sciences District. This relocation is an expansion, which reflects Cytek’s commitment to the EMEA region and highlights the company’s ongoing investment in delivering world-class solutions, training, and support to researchers and clinicians worldwide.

The new site houses Cytek European offices and warehouse, which has increased the footprint by more than 40%, with a dedicated customer service and training center. The Training Center offers a fully functional lab environment, enabling researchers to receive hands-on training with Cytek instruments. This ensures scientists can maximize the potential of Cytek’s Full Spectrum Profiling (FSP) technology to unlock high-dimensional data and enable laboratories to achieve more with fewer resources.

The success of Cytek’s reagent business is one of the major drivers of this expansion, signaling its importance to Cytek’s global growth and innovation. As part of a strategic initiative to advance its reagent business, Cytek has transitioned warehouse operations in-house. This strengthens operational oversight, ensuring the highest standards of quality and control across the supply chain. The approach enhances organizational agility, improves operational efficiency, and accelerates turnaround times, delivering a consistent and dependable experience for customers.

“Europe has been a key region in Cytek’s global growth journey, and we are making investments to strengthen our presence there,” said Wenbin Jiang, Ph.D., CEO of Cytek Biosciences. “The new Amsterdam facility expands our capabilities across the EMEA region, enabling us to more efficiently deliver solutions and services that advance scientific understanding, accelerate data-driven decision-making, and foster innovation.”

About Cytek Biosciences
Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora, Northern Lights, Cytek Aurora CS and Cytek Aurora Evo systems; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometers and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.